Alivus Life Sciences Ltd.

The revenue zoomed 10.04% to Rs. 5140.57 millions for the quarter ended March 2022 as compared to Rs. 4671.63 millions during the corresponding quarter last year.The Net proft of the company remain more or less same to Rs. 988.97  millions from Rs. 1046.84 millions ,decline by -5.53%.Operating Profit reported a sharp decline to 1473.06 millions from 1702.26 millions in the corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202203	202103	% Var	202203	202103	% Var	202203	202103	% Var
Sales	5140.57	4671.63	10.04	21232.14	18851.65	12.63	21232.14	18851.65	12.63
Other Income	50.95	3.41	1394.13	147.04	8.11	1713.07	147.04	8.11	1713.07
PBIDT	1473.06	1702.26	-13.46	6307.64	5918.85	6.57	6307.64	5918.85	6.57
Interest	1.25	211.78	-99.41	279.62	875.47	-68.06	279.62	875.47	-68.06
PBDT	1471.81	1490.48	-1.25	6028.02	5043.38	19.52	6028.02	5043.38	19.52
Depreciation	95.54	84.26	13.39	378.77	333.94	13.42	378.77	333.94	13.42
PBT	1376.27	1406.22	-2.13	5649.25	4709.44	19.96	5649.25	4709.44	19.96
TAX	387.30	359.38	7.77	1462.01	1193.63	22.48	1462.01	1193.63	22.48
Deferred Tax	18.25	11.94	52.85	85.74	66.17	29.58	85.74	66.17	29.58
PAT	988.97	1046.84	-5.53	4187.24	3515.81	19.10	4187.24	3515.81	19.10
Equity	245.05	19.60	1150.26	245.05	19.60	1150.26	245.05	19.60	1150.26
PBIDTM(%)	28.66	36.44	-21.36	29.71	31.40	-5.38	29.71	31.40	-5.38